Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 4/20 | 0.71 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.71 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
| ▸ | HTR2C | P28335 | 1/20 | 0.40 |
| ▸ | HTR2B | P41595 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14747602 | 0.90 | PTGS2 (0.70) | PTGS2PTGS1POLB | |
| SCHEMBL6342810 | 0.84 | PTGS2 (1.00) | PTGS2PTGS1 | |
| SCHEMBL14747815 | 0.82 | PTGS2 (0.54) | PTGS2PTGS1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL14747800 | 0.78 | PTGS2 (0.50) | PTGS2PTGS1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL9267572 | 0.78 | PTGS2 (0.47) | PTGS2PTGS1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL14747799 | 0.77 | PTGS2 (0.47) | PTGS2PTGS1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL29248058 | 0.77 | POLB (0.50) | PTGS2PTGS1POLB | |
| SCHEMBL8689482 | 0.75 | PTGS2 (0.67) | PTGS2PTGS1 | |
| SCHEMBL14747603 | 0.73 | PTGS2 (0.55) | PTGS2PTGS1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL19087096 | 0.72 | PTGS1 (0.42) | PTGS2PTGS1CYP1A2CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE44048-E1 | 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-YL]benzenesulfonamide for the treatment of inflammation or an inflammation-associated disorder | G.D. SEARLE LLC (US) | 2013-03-05 | — | — | US | disclosed |